Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The association of SNP276G>T at adiponectin gene with circulating adiponectin and insulin resistance in response to mild weight loss

International Journal of Obesity volume 30, pages 1702–1708 (2006)Cite this article

Abstract

Objective:

The purpose of this study was to determine whether common single nucleotide polymorphisms (SNPs) at the adiponectin (ADIPOQ) locus influence changes in circulating adiponectin and the features of insulin resistance in response to a weight loss intervention.

Subjects:

In total, 294 nondiabetic/overweight–obese Koreans participated in a clinical intervention study lasting 12 weeks involving a caloric reduction of −300kcal/day.

Methods:

Plasma adiponectin, blood lipids, glucose and insulin concentrations were measured at baseline and after weight loss. Insulin resistance was estimated by homeostasis model assessment insulin resistance (HOMA-IR) derived from fasting glucose and insulin concentrations. We genotyped for three SNPs, 45T>G, 276G>T and −11377C>G.

Results:

At baseline, HOMA-IR was significantly higher in GG homozygotes than in carriers of the T allele at SNP276G>T of the adiponectin gene (P<0.05). With regard to SNP45T>G and SNP −11377C>G, we did not find any genotype related differences in baseline levels of HOMA-IR and adiponectin. In the 45/276 haplotype test, homozygous for the TG haplotype had significantly lower concentrations of plasma adiponectin (P<0.05). After the 12-week weight loss intervention, the significant decreases in HOMA-IR (P<0.001) and increases in adiponectin (P<0.01) were observed in GG homozygotes at SNP276, which were not shown in carriers of the T allele. Furthermore, there was a significant difference in the decreases in HOMA-IR between the GG homozygotes and carriers of the T allele at SNP276 (P<0.05). Regarding SNP45T>G and SNP −11377C>G, there was no association between SNP45T>G and SNP −11377C>G and decreases in HOMA-IR. In the 45/276 haplotype test, there was a significant difference in changes of adiponectin levels among those with different haplotype combinations (P<0.05).

Conclusion:

The SNP276G>T of the ADIPOQ gene is associated with different responses of circulating adiponectin and insulin resistance to mild weight loss in overweight-obese subjects.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Nutrition Survey Health Examination. Ministry of Health and Welfare. Nutrition Survey Health Examination: Seoul, South Korea, 2002.

  2. Klein S . Outcome success in obesity. Obes Res 2001; 9: 354S–358S.

    Article  Google Scholar 

  3. Davidson MH, Hauptman J, DiGirolamo M, Foreyt JP, Halsted CH, Heber D et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. JAMA 1999; 281: 235–242.

    Article  CAS  Google Scholar 

  4. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930–1935.

    Article  CAS  Google Scholar 

  5. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595–1599.

    Article  CAS  Google Scholar 

  6. Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G . Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 2002; 25: 971–976.

    Article  Google Scholar 

  7. Matsubara M, Maruoka S, Katayose S . Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002; 87: 2764–2769.

    Article  CAS  Google Scholar 

  8. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815–3819.

    Article  CAS  Google Scholar 

  9. Fruebis J, Tsao TS, Javorschi S . Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001; 98: 2005–2010.

    Article  CAS  Google Scholar 

  10. Garaulet M, Viguerie N, Porubsky S, Klimcakova E, Clement K, Langin D et al. Adiponectin gene expression and plasma values in obese women during very-low-calorie diet. Relationship with cardiovascular risk factors and insulin resistance. J Clin Endocrinol Metab 2001; 89: 756–760.

    Article  Google Scholar 

  11. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002; 11: 2607–2614.

    Article  CAS  Google Scholar 

  12. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002; 52: 536–540.

    Article  Google Scholar 

  13. Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002; 51: 2306–2312.

    Article  CAS  Google Scholar 

  14. Chandran M, Phillips SA, Ciaraldi T, Henry RR . Adiponectin: more than just another fat cell hormone? Diabetes Care 2003; 26: 2442–2450.

    Article  CAS  Google Scholar 

  15. Steering Committee. Assessment diagnosis. The Asia-Pacific perspective: redefining obesity and its treatment, 2002. pp 15–21.

  16. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.

    Article  Google Scholar 

  17. Case CC, Jones PH, Nelson K, O'Brian SE, Ballantyne CM . Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab 2002; 4: 407–414.

    Article  CAS  Google Scholar 

  18. Haluzik M, Parizkova J, Haluzik MM . Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 2004; 53: 123–129.

    CAS  PubMed  Google Scholar 

  19. Faraj M, Havel PJ, Phelis S, Blank D, Sniderman AD, Cianflone K . Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003; 88: 1594–1602.

    Article  CAS  Google Scholar 

  20. Hulver MW, Zheng D, Tanner CJ, Houmard JA, Kraus WE, Slentz CA et al. Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 2002; 283: E861–E865.

    Article  CAS  Google Scholar 

  21. Thamer C, Haap M, Bachmann O, Zur Nieden T, Tschritter O, Stefan N et al. Serum adiponectin levels predict the effect of short-term dietary interventions on insulin sensitivity in humans. Diabetologia 2004; 47: 1303–1305.

    Article  CAS  Google Scholar 

  22. Stumvoll M, Tschritter O, Fritsche A . Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 2002; 51: 37–41.

    Article  CAS  Google Scholar 

  23. Bacci S, Menzaghi C, Ercolino T, Ma X, Rauseo A, Salvemini L et al. The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 2004; 27: 2015–2020.

    Article  CAS  Google Scholar 

  24. Qi L, Li T, Rimm E, Zhang C, Rifai N, Hunter D et al. The +276 Polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 2005; 54: 1607–1610.

    Article  CAS  Google Scholar 

  25. Gu HF, Abulaiti A, Ostenson CG, Humphreys K, Wahlestedt C, Brookes AJ et al. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians. Diabetes 2004; 53: S31–S35.

    Article  CAS  Google Scholar 

  26. Jang Y, Lee JH, Chae JS, Kim OY, Koh SJ, Kim JY et al. Association of the +276G&gt;T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans. Am J Clin Nutr 2005; 82: 760–767.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Patty W Siri of Children's Hospital Oakland Research Institute (CHORI) for her expert help. Financial support: (1) National Research Laboratory project, Ministry of Science & Technology (2005-01572) (2) Korea Science and Engineering Foundation (R01-2003-0000-11709-0) (3) Korea Health 21 R&D Projects, Ministry of Health & Welfare (00-PJ3-PG6-GN-01-0001), Republic of Korea (4) NIH/NHLBI # HL54776, and contracts 53-K06-5-10 and 58-1950-9-001 from the US Department of Agriculture Research Service (5) Korea Health 21 R&D Projects, Ministry of Health & Welfare, Republic of Korea (02-PJ1-PG1-CH15-0001).

Author information

Authors and Affiliations

  1. Yonsei Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea

    M-J Shin & Y Jang

  2. Yonsei University Research Institute of Science for Aging, Yonsei University, Seoul, Korea

    Y Jang, S J Koh, J S Chae, O Y Kim & J H Lee

  3. DNA Link Corporation, Seoul, Korea

    J E Lee

  4. Nutrition and Genomics Laboratory, JM-USDA-HNRCA, Tufts University, Boston, MA, USA

    J M Ordovas

  5. Department of Food & Nutrition, College of Human Ecology, Yonsei University, Seoul, Korea

    J H Lee

Authors
  1. M-J Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y Jang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S J Koh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J S Chae
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. O Y Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J E Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J M Ordovas
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J H Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J H Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shin, MJ., Jang, Y., Koh, S. et al. The association of SNP276G>T at adiponectin gene with circulating adiponectin and insulin resistance in response to mild weight loss. Int J Obes 30, 1702–1708 (2006). https://doi.org/10.1038/sj.ijo.0803338

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803338

Keywords

This article is cited by

Search

Advanced search

Quick links